Globus Medical, Inc. (GMED) News
Filter GMED News Items
GMED News Results
|Loading, please wait...|
GMED News Highlights
- GMED's 30 day story count now stands at 10.
- Over the past 24 days, the trend for GMED's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about GMED are AMP, TALK and SG.
Latest GMED News From Around the Web
Below are the latest news stories about GLOBUS MEDICAL INC that investors may wish to consider to help them evaluate GMED as an investment opportunity.
NuVasive (NUVA), GMED Merger Aids, Macro Woes Mar Growth
According to NuVasive (NUVA), the combined company is set to have an advanced commercial scale and portfolio of clinically proven solutions.
Is Now The Time To Put Globus Medical (NYSE:GMED) On Your Watchlist?
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Bear of the Day: NuVasive (NUVA)
Softer results for spinal surgery innovator plus questionable merger have dropped estimates and shares
Globus Medical, Inc. (NYSE:GMED) Q4 2022 Earnings Call Transcript
Globus Medical, Inc. (NYSE:GMED) Q4 2022 Earnings Call Transcript February 21, 2023 Operator: Thank you for standing by and welcome to Globus Medical’s Fourth Quarter and Full-Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. I will now turn […]
Globus Medical Full Year 2022 Earnings: EPS Misses Expectations
Globus Medical ( NYSE:GMED ) Full Year 2022 Results Key Financial Results Revenue: US$1.02b (up 6.8% from FY 2021). Net...
Globus Medical, Inc. (GMED) Q4 2022 Earnings Call Transcript
Globus Medical, Inc. (GMED)
Q4 2022 Earnings Conference Call
February 21, 2023 4:30 PM ET
Brian Kearns - Senior Vice President of Business Development and Investor Relations
Dan Scavilla - President and CEO
Keith Pfeil - Senior Vice President and Chief Financial Officer
Conference Call Participants
Shagun Singh - RBC Capital Markets
Matt Taylor - Jefferies
Matt Miksic - Barclays
Vik Chopra - Wells Fargo
David Saxon - Needham and Company
Steve Lichtman - Oppenheimer
Matthew O'Brien - Piper Sandler
Craig Bijou - Bank of America
Kyle Rose - Canaccord Genuity
Mathew Blackman - Stifel
Richard Newitter - Truist
Globus Medical (GMED) Q4 Earnings Beat, Operating Margin Rises
Globus Medical (GMED) reports strong fourth-quarter sales growth amid currency headwinds and lingering COVID-19 impacts.
Globus Medical (GMED) Q4 2022 Earnings Call Transcript
Thank you for standing by, and welcome to Globus medical's fourth quarter and full year 2022 earnings conference call. Joining today's call from Globus Medical will be Dan Scavilla, president and CEO; and Keith Pfeil, chief financial officer.
Globus Medical (GMED) Tops Q4 Earnings Estimates
Globus Medical (GMED) delivered earnings and revenue surprises of 7.27% and 0.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Globus Medical Reports Fourth Quarter and Full Year 2022 Results
AUDUBON, Pa., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2022. Fourth Quarter 2022: Worldwide net sales were $274.5 million, an increase of 9.8%, or 11.7% on a constant currency basisGAAP net income for the quarter was $50.1 millionGAAP diluted earnings per share (“EPS”) was $0.49 and non-GAAP diluted EPS was $0.59Non-GAAP adjusted EBITDA